Pharma crusader takes India's drug regulators to court
Dinesh Thakur is accusing them of failing to enforce rules on drug safety in US$15 billion industry
Add BT as a preferred source
New Delhi
ONE of India's best-known whistleblowers, who exposed dangerous practices in the generic drug industry in 2013, is taking the country's drugs regulators to court, accusing them of failing to enforce rules on drug safety in the US$15 billion industry.
Three years ago, Dinesh Thakur exposed how India's then largest drugmaker and his former employer, Ranbaxy Laboratories, failed to conduct proper safety and quality tests on drugs and lied to regulators about its procedures. He made his name, and almost US$48 million as a whistleblower award from the United States, when US regulators fined Ranbaxy US$500 million for violating federal drug safety laws and making false statements to the Food and Drug Administration (FDA).
Share with us your feedback on BT's products and services
